北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (6): 1196-1201. doi: 10.19723/j.issn.1671-167X.2022.06.023

• 论著 • 上一篇    下一篇

新型生物陶瓷材料用于乳磨牙牙髓切断术的临床疗效

王爽,彭楚芳,刘鹤*()   

  1. 北京大学口腔医学院·口腔医院儿童口腔科,国家口腔医学中心,国家口腔疾病临床医学研究中心,口腔生物材料和数字诊疗装备国家工程研究中心,口腔数字医学北京市重点实验室,国家卫生健康委员会口腔医学计算机应用工程技术研究中心,国家药品监督管理局口腔生物材料重点实验室,北京 100081
  • 收稿日期:2020-03-12 出版日期:2022-12-18 发布日期:2022-12-19
  • 通讯作者: 刘鹤 E-mail:heliu69@126.com
  • 基金资助:
    北京大学口腔医院临床新技术新疗法项目(PKUSSNCT-18B10)

Pulpotomy of human primary molars with novel bioceramic material

Shuang WANG,Chu-fang PENG,He LIU*()   

  1. Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Research Center of Engineering and Technology for Computerized Dentistry & NMPA Key Laboratory for Dental Materials, Beijing 100081, China
  • Received:2020-03-12 Online:2022-12-18 Published:2022-12-19
  • Contact: He LIU E-mail:heliu69@126.com
  • Supported by:
    the New Clinical Technology and New Therapy Project of Peking University Hospital of Stomatology(PKUSSNCT-18B10)

RICH HTML

  

摘要:

目的: 对新型生物陶瓷材料iRoot BP Plus和三氧化矿物凝聚体(mineral trioxide aggregate, MTA)作为盖髓剂应用于乳磨牙牙髓切断术的疗效进行评价,比较两者成功率,并分析影响因素。方法: 通过检索北京大学口腔医院电子病历数据库,筛选2017年1月至2018年12月期间于北京大学口腔医院儿童口腔科门诊就诊、有乳磨牙诊断为慢性牙髓炎、行牙髓切断术的患儿,选择符合纳入标准且盖髓剂为iRoot BP Plus或MTA的患牙,盖髓剂为iRoot BP Plus的患牙全部纳入实验组(iRoot BP Plus组),使用倾向评分匹配法选择性别、年龄、牙位、医生级别、牙髓状态、冠部修复方式和随访时长作为协变量进行1 ∶ 1匹配盖髓剂为MTA的患牙纳入对照组(MTA组)。收集各组患牙治疗前自觉症状、临床检查、影像学表现、治疗情况、随访情况,比较两组治疗成功率,并分别分析影响因素。结果: 共纳入132例患儿,178颗患牙,每组各89颗,平均随访时间(462±99) d,截止至2019年12月,iRoot BP Plus组和MTA组成功率分别为89.9%、93.3%,iRoot BP Plus组成功率稍低于MTA组,差异无统计学意义。通过Cox比例风险模型进行分析发现,牙髓状态的好坏显著影响iRoot BP Plus组的治疗成功率,而年龄、牙位、医生级别、冠部修复方式对成功率均无显著影响。结论: iRoot BP Plus作为盖髓剂应用于乳磨牙牙髓切断术可以取得与MTA相似的治疗效果,牙髓状态是影响治疗效果的主要因素,其远期疗效及影响因素仍需进行更大样本、更长随访时间的研究。

关键词: 牙髓切断术, 新型生物陶瓷材料, 慢性牙髓炎

Abstract:

Objective: To evaluate the efficacy of iRoot BP Plus, a novel bioceramic material, and mineral trioxide aggregate (MTA) by comparing the clinical and radiographic results of pulpotomy in human primary molars, and to find out the influence factor. Methods: Children who had at least one primary molar diagnosed as pulpitis, and received pulpotomy in the Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology from January, 2017 to December, 2018 were searched by the selection criteria in the Electronic Medical Record Database of Peking University School and Hospital of Stomatology. The molars with the pulp capping agents were iRoot BP Plus or MTA were included, and the molars with other pulp capping agents were excluded. Molars using iRoot BP Plus were selected into the experimental group (iRoot BP Plus group). Molars using MTA were selected into the control group (MTA group) using propensity score matching model (1 ∶ 1), considering the gender, age, tooth position, the title of clinician, pulp status, restoration and length of follow-up as the potential influence factor. Basic information, the relevant medical records including symptoms, clinical and radiographic examination before and after operation, intraoperative information and follow up examination records were collected. The success rates were compared and the influence factors were analyzed respectively. Results: The study included 132 children, 178 molars (89 molars from each group) and the mean follow-up time was (462±99) days by December, 2019. In the iRoot BP Plus group, 9 molars failed whilst 6 molars failed in MTA group. The success rate was 89.9% and 93.3%, respectively, showing no significant difference between the two groups. Through Cox proportional risk model analysis, the success rate of iRoot BP Plus was significantly lower when the pulp status was poor, while other factors including age, tooth position, title of clinician and restoration were not found to be associated with the clinical outcome. Conclusion: Pulpotomy of human primary molars with iRoot BP Plus has the same effectiveness with MTA. The pulp status is the main factor that influences the outcome of iRoot BP Plus. Further studies with larger sample sizes and longer follow-up terms are needed.

Key words: Pulpotomy, Novel bioceramic material, Pulpitis

中图分类号: 

  • R788.2

表1

倾向评分匹配前后iRoot BP Plus组和MTA组牙齿信息(以牙为单位)"

ItemsBefore PSMPAfter PSMP
iRoot BP Plus
(n=89)
MTA
(n=1 434)
iRoot BP Plus
(n=89)
MTA
(n=89)
Gender, n(%) 0.750 1.000
  Male 45(51.6) 750(52.3) 45(51.6) 45(51.6)
  Female 44(49.4) 684(47.7) 44(49.4) 44(49.4)
Age/years 5.11±0.98 5.71±1.81 0.008 5.11±0.98 5.21±1.04 0.518
Tooth position, n(%) 0.442 0.812
  Maxillary first primary molar 22(24.7) 387(27.0) 22(24.7) 24(27.0)
  Maxillary second primary molar 14(15.7) 336(23.4) 14(15.7) 18(20.2)
  Mandibular first primary molar 23(25.8) 315(22.0) 23(25.8) 20(22.5)
  Mandibular first primary molar 30(33.7) 396(27.6) 30(33.7) 27(30.3)
Title of clinician, n(%) 0.000 0.524
  Resident doctor & intern 26(29.2) 734(51.2) 26(29.2) 28(31.5)
  Attending doctor 60(67.4) 466(32.5) 60(67.4) 55(61.8)
  Professor 3(3.4) 234(16.3) 3(3.4) 6(6.7)
Pulp status, n(%) 0.035 0.593
  Good 67(75.3) 1180(82.3) 67(75.3) 70(78.7)
  Poor 22(24.7) 254(17.7) 22(24.7) 19(21.3)
Restoration, n(%) 0.000 0.225
  Composite resin 82(92.1) 1017(70.9) 82(92.1) 77(86.5)
  Stainless steel crown 7(7.9) 417(29.1) 7(7.9) 12(13.5)
Length of follow-up/d, $\bar x \pm s$ 454±93 498±268 0.019 454±93 470±104 0.299

图1

iRoot BP Plus组和MTA组生存曲线"

表2

iRoot BP Plus组和MTA组Cox比例风险回归分析"

Influence factorsiRoot BP Plus MTA
Exp(B)95%CI for Exp(B)P Exp(B)95%CI for Exp(B)P
Lower UpperLower Upper
Pulp status 0.081 0.016 0.410 0.002 1.005 0.105 9.642 0.996
Age 0.643 0.251 1.645 0.357 1.349 1.002 3.229 0.439
Title of clinician 0.993 0.369
Tooth position 0.547 0.982
Restoration 20 822 0.000 1.276×108 0.973 0.999 0.085 11.691 1.000
1 Fuks AB . Current concepts in vital primary pulp therapy[J]. Eur J Paediatr Dent, 2002, 3 (3): 115- 120.
2 Subramaniam P , Konde S , Mathew S , et al. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study[J]. J Clin Pediatr Dent, 2009, 33 (4): 311- 314.
doi: 10.17796/jcpd.33.4.r83r38423x58h38w
3 Tani-Ishii N , Hamada N , Watanabe K , et al. Expression of bone extracellular matrix proteins on osteoblast cells in the presence of mineral trioxide[J]. J Endod, 2007, 33 (7): 836- 839.
doi: 10.1016/j.joen.2007.02.003
4 Moghaddame-Jafari S , Mantellini MG , Botero TM , et al. Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro[J]. J Endod, 2005, 31 (5): 387- 391.
doi: 10.1097/01.don.0000145423.89539.d7
5 Alsubait S , Al-Haidar S , Al-Sharyan N . A comparison of the discoloration potential for endosequence bioceramic root repair material fast set putty and ProRoot MTA in human teeth: An in vitro study[J]. J Esthet Restor Dent, 2017, 29 (1): 59- 67.
doi: 10.1111/jerd.12264
6 Moinzadeh AT , Portoles CA , Wismayer PS , et al. Bioactivity potential of endo sequence BCRRM putty[J]. J Endod, 2016, 42 (4): 615- 621.
doi: 10.1016/j.joen.2015.12.004
7 Rifaey HS , Villa M , Zhu Q , et al. Comparison of the osteogenic potential of mineral trioxide aggregate and endosequence root repair material in a 3-dimensional culture system[J]. J Endod, 2016, 42 (5): 760- 765.
doi: 10.1016/j.joen.2016.02.001
8 Shokouhinejad N , Nekoofar MH , Razmi H , et al. Bioactivity of endosequence root repair material and Bioaggregate[J]. Int Endod J, 2012, 45 (12): 1127- 1134.
doi: 10.1111/j.1365-2591.2012.02083.x
9 Carvalho CN . Effect of root repair materials and bioactive glasses on microhardness of dentin[J]. Iran Endod J, 2018, 13 (3): 337- 341.
10 Caliendo M , Kopeinig S . Some practical guidance for the implementation of propensity score matching[J]. J Econ Surv, 2005, 22 (1): 31- 72.
11 Taha NA , Safadi RA , Alwedaie MS . Biocompatibility evaluation of EndoSequence root repair paste in the connective tissue of rats[J]. J Endod, 2016, 42 (10): 1523- 1528.
doi: 10.1016/j.joen.2016.07.017
12 Zhang J , Zhu LX , Cheng X , et al. Promotion of dental pulp cell migration and pulp repair by a bioceramic putty involving FGFR-mediated signaling pathways[J]. J Dent Res, 2015, 94 (6): 853- 862.
doi: 10.1177/0022034515572020
13 Zhang S , Yang X , Fan M . BioAggregate and iRoot BP Plus optimize the proliferation and mineralization ability of human dental pulp cells[J]. Int Endod J, 2013, 46 (10): 923- 929.
doi: 10.1111/iej.12082
14 Öncel TZ , Torun D , Demirkaya K , et al. Effects of iRoot BP and white mineral trioxide aggregate on cell viability and the expression of genes associated with mineralization[J]. Int Endod J, 2015, 48 (10): 986- 993.
doi: 10.1111/iej.12393
15 Liu S , Wang S , Dong Y . Evaluation of a bioceramic as a pulp capping agent in vitro and in vivo[J]. J Endod, 2015, 41 (5): 652- 657.
doi: 10.1016/j.joen.2014.12.009
16 雷玥, 杨颖婷, 战园. 生物陶瓷材料在乳牙牙髓切断术中的应用[J]. 北京大学学报(医学版), 2019, 51 (1): 70- 74.
17 Matthias Z , Nicolas D , Yunling D , et al. Cytokine gene expression: Part of host defence in pulpitis[J]. Cytokine, 2003, 22 (3): 84- 88.
18 Wang Z , Ma J , Shen Y , et al. Acidic pH weakens the microhardness and microstructure of three tricalcium silicate materials[J]. Int Endod J, 2015, 48 (4): 323- 332.
doi: 10.1111/iej.12318
19 Hansen SW , Marshall JG , Sedgley CM . Comparison of intracanal EndoSequence root repair material and ProRoot MTA to induce pH changes in simulated root resorption defects over 4 weeks in matched pairs of human teeth[J]. J Endod, 2011, 37 (4): 502- 506.
doi: 10.1016/j.joen.2011.01.010
20 Asgary S , Eghbal MJ . Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: A multi-center randomized controlled trial[J]. Acta Odontol Scand, 2013, 71 (1): 130- 136.
doi: 10.3109/00016357.2011.654251
21 Holan G , Fuks AB , Ketlz N . Success rate of formocresol pulpotomy in primary molars restored with stainless steel crown vs. amalga[J]. Pediatr Dent, 2002, 24 (3): 212- 216.
22 Soxman JA . Stainless steel crown and pulpotomy: procedure and technique for primary molars[J]. Gen Dent, 2000, 48 (3): 294- 297.
23 Dhar V , Marghalani AA , Crystal YO . Use of vital pulp therapies in primary teeth with deep caries lesions[J]. Pediatr Dent, 2017, 39 (5): 146- 159.
24 Ibricevic H , Al-Jame Q . Ferric sulfate as pulpotomy agent in primary teeth: Twenty month clinical follow-up[J]. J Clin Pediatr Dent, 2000, 24 (4): 269- 272.
[1] 郑佳佳,杨雪,温泉,付元,邵校,丁美丽. 生物活性陶瓷iRoot BP Plus®在儿童年轻恒前牙复杂冠折牙髓切断术中的应用[J]. 北京大学学报(医学版), 2024, 56(1): 179-184.
[2] 赵晓一,刘畅,钱锟,潘洁. 成熟恒牙牙髓切断术的疗效及影像学评价[J]. 北京大学学报(医学版), 2024, 56(1): 138-143.
[3] 雍颹,钱锟,朱文昊,赵晓一,刘畅,潘洁. 成年恒牙牙髓切断后牙髓钙化的X线片评价[J]. 北京大学学报(医学版), 2023, 55(1): 88-93.
[4] 钱锟,潘洁,朱文昊,赵晓一,刘畅,雍颹. 两种硅酸钙类材料用于成熟恒牙牙髓切断术的临床效果[J]. 北京大学学报(医学版), 2022, 54(1): 113-118.
[5] 雷玥,杨颖婷,战园. 生物陶瓷材料在乳牙牙髓切断术中的应用[J]. 北京大学学报(医学版), 2019, 51(1): 70-74.
[6] 窦桂丽,吴南,赵双云,夏斌. 乳磨牙牙髓切断术两年疗效观察及其影响因素回顾性分析[J]. 北京大学学报(医学版), 2018, 50(1): 170-175.
[7] 郭怡丹,张笋. Er:YAG激光用于比格犬牙髓切断术[J]. 北京大学学报(医学版), 2016, 48(4): 714-719.
[8] 郑佳佳,陈小贤,张笋,葛立宏. 中日两国部分口腔医师乳牙活髓保存诊疗操作现况调查[J]. 北京大学学报(医学版), 2015, 47(6): 1050-1052.
[9] 白洁, 秦满, 姬爱平. Pulpdent Multi-Cal用于年轻恒前牙活髓切断术的临床研究[J]. 北京大学学报(医学版), 2011, 43(6): 882-885.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 钟金晟, 欧阳翔英, 梅芳, 邓旭亮, 曹采方. 多孔β-磷酸三钙/胶原支架与犬牙周膜细胞三维复合体的构建[J]. 北京大学学报(医学版), 2007, 39(5): 507 -510 .
[2] 张奇, 罗国安, 邓英杰. 均匀设计法制备5-氟尿嘧啶脂质体及其稳定性[J]. 北京大学学报(医学版), 2002, 34(1): 64 -67 .
[3] 管宏, 赵慧云, 沈磊, 李五岭, 王建华, 王春荣, 徐福. 联合应用重组TPO和G-CSF对骨髓抑制性小鼠外周血小板及白细胞恢复的影响[J]. 北京大学学报(医学版), 2001, 33(2): 181 -182 .
[4] 李云芳, 张幼怡, 侯嵘, 董尔丹, 韩启德. 质粒转染对HEK293和DDT1-MF2细胞天然β2-肾上腺素受体表达的影响[J]. 北京大学学报(医学版), 2001, 33(5): 457 -461 .
[5] 柯杨. 乳头状瘤病毒与人类肿瘤[J]. 北京大学学报(医学版), 2002, 34(5): 599 -603 .
[6] 赵建新, 周良, 万远廉. 经十二指肠逆行放置支架治疗恶性幽门梗阻2例[J]. 北京大学学报(医学版), 2002, 34(6): 737 -738 .
[7] 洪涛, 霍勇. COURAGE试验后稳定型心绞痛的治疗策略思考[J]. 北京大学学报(医学版), 2007, 39(6): 562 -564 .
[8] 牟向东, 王广发, 阙呈立, 李桂莲. H3N2型人流行性感冒合并金黄色葡萄球菌败血症及金黄色葡萄球菌肺炎1例[J]. 北京大学学报(医学版), 2007, 39(6): 663 -665 .
[9] 李智岗, 黄景香, 李顺宗, 赵俊京, 时高峰, 梁国庆, 王红光, 韩捧银, 王琦, 谷铁树. 肝转移瘤的血供[J]. 北京大学学报(医学版), 2008, 40(2): 146 -150 .
[10] 冯现竹, 侯平, 朱厉, 于磊, 张宏. 转铁蛋白受体基因多态性与IgA肾病易感性及临床病理表型的相关性[J]. 北京大学学报(医学版), 2008, 40(4): 369 -373 .